Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma
Journal of Surgical Oncology · 2023-04 · 127 (5) · 855-861
DOI: 10.1002/jso.27199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 09.01.2023. Verfasst von Aida Nasirishargh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California Davis Medical Center, Sacramento, California, USA. Hauptthemen laut MEDLINE: Frailty, Sarcopenia, Hypoalbuminemia, Retroperitoneal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Retroperitoneal sarcomas (RPS) are rare tumors for which surgical resection is the principal treatment. There is no established model to predict perioperative risks for RPS. We evaluated the association between preoperative sarcopenia, frailty, and hypoalbuminemia with surgical and oncological outcomes.
Methods
We performed a prospective cohort analysis of 65 RPS patients who underwent surgical resection. Sarcopenia was defined as Total Psoas Area Index ≤ 1st quintile by sex. Frailty was estimated using the modified frailty index (mFI). Logistic regression models were used to assess predictors of 30‐day postoperative morbidity. The Kaplan–Meier method with log‐rank test was utilized to assess factors associated with overall (OS) and recurrence‐free survival (RFS).
Result
Sarcopenia was associated with worse OS with a median of 54 compared with 158 months ( p = 0.04), but no differences in RFS ( p > 0.05). Hypoalbuminemia was associated with worse OS with a median of 72 compared with 158 months ( p < 0.01). MFI scores were not associated with OS or RFS ( p > 0.05). Sarcopenia, mFI, and hypoalbuminemia were not associated with postoperative morbidity ( p > 0.05).
Conclusion
This study suggests that sarcopenia may be utilized as a measure of overall fitness, rather than a cancer‐specific risk, and the mFI is a poor predictive measure of outcomes in RPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of California Davis Medical Center, Sacramento, California, USA.
- Department of Radiology, University of California Davis Medical Center, Sacramento, California, USA.
- Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Zitieren
APA
Nasirishargh, A., Grova, M., Bateni, C. P., Judge, S. J., Nuno, M. A., Basmaci, U. N., Canter, R. J., & Bateni, S. B. (2023). Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma. Journal of Surgical Oncology, 127(5), 855-861. https://doi.org/10.1002/jso.27199
Vancouver
Nasirishargh A, Grova M, Bateni CP, Judge SJ, Nuno MA, Basmaci UN, et al. Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma. Journal of Surgical Oncology. 2023;127(5):855-861. doi:10.1002/jso.27199
BibTeX
@article{Nasirishargh2023,
author = {Nasirishargh, Aida and Grova, Monica and Bateni, Cyrus P and Judge, Sean J and Nuno, Miriam A and Basmaci, Ugur Nur and Canter, Robert J and Bateni, Sarah B},
title = {Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma},
journal = {Journal of Surgical Oncology},
year = {2023},
volume = {127},
number = {5},
pages = {855--861},
doi = {10.1002/jso.27199}
}
EUVIMED